# 1. Financial Performance ## A. Key Figures * **Consolidated Sales:** **₹800 Cr** (Q1 FY26) (+16% YoY) · **₹116 Cr** EBITDA (Q1 FY26) (+38% YoY) * **BOPP Film Margin:** **₹25/kg** (Q1 FY26) (+₹6/kg vs. Q4 FY25) * **Specialty Chemicals EBITDA:** **₹12 Cr** (Record Q1) on **₹49 Cr** sales * **Net Debt:** **₹1,140 Cr** (as of Jun-25) ## B. Revenue & Volume * **Strong Volume-Led Growth:** Top-line expansion driven by **robust 19% volume growth** and pricing power in BOPP films, achieving highest quarterly turnover since Jun-2022. * **Emerging Contributor:** Q1 GMV from new verticals near **₹16 Cr**, indicating early traction in ancillary revenue streams. ## C. EBITDA & Margins * **Margin Expansion Underway:** EBITDA surge reflects improved BOPP film margins, **cost rationalization savings of ₹4 Cr**, and **₹4 Cr improvement in specialty chemicals**. * **Positive Forward Signal:** BOPP exit margins expected near **₹30/kg**, suggesting further margin uplift in near term. * **Headwinds in New Verticals:** Rigid packaging and Cosmo consumer segments currently dilutive due to elevated **marketing and employee costs**. ## D. Balance Sheet * **Peak Leverage Likely Passed:** Net debt at **₹1,140 Cr** expected to stabilize as capex cycle winds down and working capital normalizes. --- # 2. Product & Segment Mix ## A. Key Figures * **Specialty & Semi-Specialty Mix:** **68%** by volume · **>80%** by value * **Revenue Geography:** **50%** domestic · **45%** exports * **Others Segment Revenue:** **₹25 Cr** in Q1 FY'26 (Sunshield & rigid packaging) * **Cost Savings:** **₹4 Cr** in Q1 · **₹40 Cr** targeted for FY'26 ## B. Specialty vs Commodity * **Strategic Shift to Specialty:** Multi-year **~10% CAGR** in specialty films, with clear roadmap to expand share over next three years amid strong early demand on new BOPP line. * **Margin Resilience:** Specialty products enable **full pass-through of raw material costs**, protecting margins, unlike commodity segment which sees volatility from short-term price spikes. * **Value Over Volume:** Despite lower volume share, specialty and semi-specialty products dominate **value contribution**, reflecting premium pricing and strategic focus. ## C. Segment Revenue Split * **Domestic-First, Global-Next:** Window films prioritized for India via **ATL/BTL marketing**, with initial export push into Americas, Europe, and Middle East. * **Segment Diversification:** Revenue spans packaging, specialty chemicals, pet care (Zigly), and emerging “others” segment, with **Cosmo consumer** (window films, PPF, coatings) and **Plastech rigid packaging** flagged as key growth vectors. ## D. New Business Contribution * **Zigly & Pet Care Expansion:** Pet care pivot to **high-margin services and house brands**, supported by **small, value-accretive vet hospital acquisitions**—one seeing **20–25% sales uplift** post-buyout. * **First-Mover in Ceramic Coatings:** Cosmo now domestically manufactures ceramic coatings, previously imported, expanding its **premium automotive care portfolio**. * **Specialty Chemicals Gain Traction:** Now a **profitable and growing vertical**, contributing meaningfully to new business momentum. --- # 3. Capacity & Utilization ## A. Key Figures * **Revenue Potential:** **₹750 Cr** annual revenue at full utilization (new BOPP line) * **Cost Impact:** **₹6–8 Cr** annual fixed cost increase (minimal) * **De-bottlenecking Gain:** **6–7%** production increase expected from existing lines * **Net Debt Change:** **₹200 Cr** increase since March (working capital for expansion) ## B. BOPP Capacity Add * **Major Expansion Live:** New ~81,000 MT BOPP line fully operational with strong ramp-up trajectory, driving near-term volume and revenue growth. * **Strategic Market Positioning:** Capacity additions coincide with net market supply reduction, tightening industry dynamics and enhancing pricing power. * **Capital Efficiency:** Expansion delivering high revenue potential with minimal fixed cost inflation, underpinning margin accretion. * **Diversified Growth Platform:** Recent commissioning of window film and other specialty lines expands addressable market and boosts competitive edge. ## C. Line Utilization Rates * **Full Utilization Achieved:** New BOPP line running at full capacity with imminent 100% ramp-up; focus shifting to higher-margin specialty film mix. * **Tight Industry Supply:** Indian BOPP sector operating at full utilization, supporting favorable demand-supply balance and potential for capacity-led pricing. ## D. De-bottlenecking Gains * **Productivity Upside:** Ongoing total quality management initiative expected to lift output from existing lines by **6–7%**, extending capacity gains without major capex. * **Cultural Transformation:** De-bottlenecking embedded in company-wide continuous improvement program with broad employee engagement, signaling sustainable operational upside. --- # 4. Demand & Pricing Trends ## A. Key Figures * **Domestic BOPP Consumption:** **65,000–70,000 tons** annually · **Exports:** **~15,000 tons** (Cosmo largest exporter) * **Capacity Exit:** **~15,000 tons** annual BOPP capacity produced by exiting major player * **New Capacity:** **11,000–12,000 tons** added/operational; **12,000 tons** already entering market ## B. Industry Supply Gap * **Supply-Demand Balance:** Market expected to remain fairly balanced through FY'26, supported by capacity exit and limited new additions, fostering stable margin conditions. * **Temporary Cushion:** Exit of major capacity created an 18–24 month favorable demand-supply dynamic, benefiting the entire industry. * **Import Normalization:** Surge in imports expected to resolve within **30–45 days**, as traders adjust to rational pricing and face losses on forced inventory liquidation. ## C. Pricing Power * **Pricing Discipline:** Management maintained rational pricing, avoiding aggressive hikes—this curbed long-term margin erosion despite short-term pressure from speculative imports. * **Product Mix Advantage:** Semi-specialty films command premium pricing, while **food-grade films benefit from import barriers**, preserving margin strength. * **Resilient Margins:** Despite import surge, value add remains **+30 for tape textile film** and **+45 for non-tape film**, indicating underlying pricing power in key segments. --- # 5. Channel & Customer Metrics ## A. Key Figures * **Zigly Online Growth:** **2–3%** (current quarter) * **Online Order Surge:** **30%** (February–March) * **Zigly Centers:** **34** operational · **>40** targeted in 3 months * **Veterinary Services Mix:** **~60%** of retail business ## B. Online Order Recovery * **Severe Channel Disruption:** Online growth stalled due to **omni-channel implementation issues**, triggering platform sanctions from Amazon and Flipkart. * **Operational Glitch, Strong Underlying Demand:** Despite cancellations, a **30% spike in online orders** post-rollout confirms robust digital demand. ## C. Store Profitability * **Path to Profitability:** Most two-year-old Zigly stores expected to turn profitable, with **older units on track for cash positivity by December**. * **Margin Pressure from Vet Staffing:** Short-term profitability weighed by higher payroll from **strategic addition of veterinary professionals**. * **Business Model Validation:** Retail economics show **profitability inflection in Year 3**, consistent with unit-level trends. ## D. Distribution Reach * **Differentiated Ecosystem:** Zigly remains the **only integrated pet care provider** offering advanced vet care, surgeries, grooming, and retail. * **Expansion Momentum:** Network growing rapidly toward **40+ centers**, supporting scale and brand consolidation. * **Channel Strategy:** Specialty products driven by **long-term contracts**, while thermal lamination leverages **global distribution networks**. --- # 6. Risks & Trade Factors ## A. Key Figures * **B. S. Exports:** **₹250–280 Cr** annually (~<10% of revenue) * **Tariff Range:** **5% → 55%** import duty on U.S. goods; **55%** proposed U.S. export duty * **Breakeven Tariff:** **20–25%** export duty considered manageable; **>50%** threatens profitability ## B. U.S. Tariff Exposure * **High Tariff Risk:** Current 55% U.S. tariff proposal poses severe threat to export viability, with potential impact on **close to 50% of the business** despite exports representing less than 10% of total revenue. * **Market Diversification Option:** Management prepared to reroute U.S.-bound exports to alternative markets if duties remain elevated, though expects resolution toward **realistic rates near 15%**. * **Profitability Threshold:** Operations remain viable at 20–25% tariffs due to pass-through capability; **above 50% would render exports unprofitable**. ## C. Import Competition * **Limited Import Threat:** BOPP imports into India are largely uneconomical due to **10% customs duty** and high logistics costs, restricting inflows to niche players using advanced license schemes. * **Quality Protection Push:** Domestic producers advocate for **BIS standards on imported films** to counter poor-quality Chinese imports, which have harmed end-user confidence. ## D. Margin Sensitivity * **Margin Resilience Confirmed:** Management asserts that **20% import duty levels are sustainable** without margin erosion, supporting pricing power and cost pass-through. --- # 7. Guidance & Outlook ## A. Key Figures * **Rigid Packaging Breakeven:** **₹25 Cr** quarterly sales target (achieve EBITDA breakeven) · **₹20–22 Cr** run rate nearing breakeven * **Rigid Packaging Capacity:** Asset base supports **₹130–160 Cr** annual sales * **Capex Outlook:** No major CAPEX planned next fiscal, enabling **significant net debt reduction** over two years ## B. Revenue Trajectory * **Growth Inflection Ahead:** Top-line momentum expected to accelerate in coming quarters, driven by **new production line ramp-up** and **45% capacity addition** effective June 1. * **Omni-Channel Recovery:** Online sales performance on track to recover fully next quarter as dispatch issues are resolved. * **Zigly Strategic Timeline:** Demerger targeted for **2028–2029**, potentially earlier; no financial partners planned within next 12 months despite global interest. * **Long-Term Value Potential:** Zigly acknowledged as a future **significant value creator**, though path to profitability will take time. ## C. EBITDA Breakeven * **Rigid Packaging Turnaround Imminent:** Positive EBITDA expected by **September–October**, with PBT anticipated in Q3 or Q4, supported by recent cost improvements. * **Volume-Driven Margin Leverage:** Bottom-line improvement anticipated from higher volumes and stable industry conditions, despite absence of long-term margin guidance. ## D. Capex Plans * **Capital Discipline:** No major CAPEX planned next fiscal, allowing for deleveraging and stronger free cash flow generation. * **Business Model Enhancement:** Focus on scaling specialty sales, cost optimization in films, and monetizing prior investments.